Oncternal Therapeutics Stock (NASDAQ: ONCT) stock price, news, charts, stock research, profile.
Open | $1.52 |
Close | $1.45 |
Volume / Avg. | 51.04K / 30.70K |
Day Range | $1.45 - $1.54 |
52 Wk Range | 1.32 - 13.14 |
Market Cap | $4.14M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 20 |
Short Interest | 0.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Oncternal Therapeutics (NASDAQ:ONCT) through any online brokerage.
Other companies in Oncternal Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and Trevena (NASDAQ:TRVN).
Oncternal Therapeutics has a consensus price target of $6.58.
The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $1.4 last updated September 23, 2024 at 4:43 PM EDT.
There are no upcoming dividends for Oncternal Therapeutics.
Oncternal Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Oncternal Therapeutics.
Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.